Part,  Chapter, Paragraph

 1   II,     5.  1.  1|            common cause of RRT for ESRD, affecting more than 22%
 2   II,     5.  7.Acr|         CKD~Chronic Kidney Disease~ESRD~End Stage Renal Disease~
 3   II,     5.  7.  1|           end stage renal disease (ESRD), i.e. the disease stage
 4   II,     5.  7.  1|   population, whilst patients with ESRD have a 100 times higher
 5   II,     5.  7.  1|           end stage renal disease (ESRD),~CKD was not listed among
 6   II,     5.  7.  1|          and progression of CKD.~ ~ESRD and the resulting cost of
 7   II,     5.  7.  1|      replacement therapy (RRT) for ESRD in children are collected
 8   II,     5.  7.  1|             Although rare, CKD and ESRD in children pose unique
 9   II,     5.  7.  1|         life engendered by CKD and ESRD both in adults (Gorodetskaya
10   II,     5.  7.  1|            society. CKD in the pre ESRD phase entails a cost excess
11   II,     5.  7.  1|          care budget was spent for ESRD patients, i.e. 0.083% of
12   II,     5.  7.  1|          dialysis)~585.5~585.6 (if ESRD)~V codes for dialysis or
13   II,     5.  7.  2|     collects data in patients with ESRD on RRT. Available data on
14   II,     5.  7.  2|          and prevalence of RRT for ESRD to the ERA-EDTA Registry
15   II,     5.  7.  3|          incidence rate of RRT for ESRD in children aged 0-14 was
16   II,     5.  7.  3|        changes in the incidence of ESRD are mainly based on NHANES
17   II,     5.  7.  3|          the USA, the incidence of ESRD appears to be increasing
18   II,     5.  7.  3|             Indeed, 9 new cases of ESRD developed in 1983 for every
19   II,     5.  7.  3|            comparison, 16 cases of ESRD had developed in 1996 for
20   II,     5.  7.  3|        versus a marked increase in ESRD was noticed in a second
21   II,     5.  7.  3|          11%). This contrasts with ESRD incidence rates which are
22   II,     5.  7.  3|          from CKD stages 3 or 4 to ESRD in US white patients compared
23   II,     5.  7.  3|         incidence rates of RRT for ESRD ranged from 57 patients
24   II,     5.  7.  3|          incidence rate of RRT for ESRD in 2005 steeply increased
25   II,     5.  7.  3|         incidence rate of diabetic ESRD.~ ~Table 5.7.3. Incidence
26   II,     5.  7.  3|          diabetic and hypertensive ESRD became twice as high, the
27   II,     5.  7.  3|           the incidence of RRT for ESRD due to glomerulonephritis/
28   II,     5.  7.  3|         incidence rates of RRT for ESRD across countries, there
29   II,     5.  7.  3|          diabetic and hypertensive ESRD (Stengel et al, 2003; van
30   II,     5.  7.  3|         decrease in some causes of ESRD, have prompted some investigators
31   II,     5.  7.  3|   strategies for the prevention of ESRD have finally started to
32   II,     5.  7.  3|         which flies in the face of ESRD statistics where men are
33   II,     5.  7.  3|         1997).~ ~The prevalence of ESRD undergoing RRT in children (<
34   II,     5.  7.  3| complications and for evolution to ESRD (Go et al, 2004) - in population-based
35   II,     5.  7.  3|        crude prevalence of RRT for ESRD varied from 321 patients
36   II,     5.  7.  3|     adjusted prevalence of RRT for ESRD increased from 480 to 807
37   II,     5.  7.  3|         USRDS 2007 ). Mortality in ESRD patients is very high. Five-year
38   II,     5.  7.  3|         which flies in the face of ESRD statistics where men are
39   II,     5.  7.  3|         incidence rates of RRT for ESRD across countries, there
40   II,     5.  7.  3|          diabetic and hypertensive ESRD (Stengel et al, 2003; van
41   II,     5.  7.  3|         decrease in some causes of ESRD, have prompted some investigators
42   II,     5.  7.  3|   strategies for the prevention of ESRD have finally started to
43   II,     5.  7.  3|      Member States.~ ~Mortality in ESRD patients is still very high.
44   II,     5.  7.  4|            common cause of RRT for ESRD, affecting more than 22%
45   II,     5.  7.  4|          rates of RRT for diabetic ESRD and differences in stages
46   II,     5.  7.  4|      number of patients developing ESRD will, among other factors,
47   II,     5.  7.  4|            of underlying causes of ESRD, by the access to and quality
48   II,     5.  7.  4|            patients have developed ESRD, they may or may not be
49   II,     5.  7.  5|          single agenda for CKD and ESRD at national level, as the
50   II,     5.  7.  5|         decrease) the incidence of ESRD and (2) to reduce the impact
51   II,     5.  7.  5|        Superiore di Sanità. As for ESRD, reporting on quality of
52   II,     5.  7.  5|        concerning the provision of ESRD treatment throughout Austria
53   II,     5.  7.  5|            of quality assurance in ESRD treatment. The Health Plan
54   II,     5.  7.  6|     essential in the prevention of ESRD and in the improvement of
55   II,     5.  7.  6|            those patients for whom ESRD cannot be prevented. Under
56   II,     5.  7.  6|          aspects on the quality of ESRD care, but also projects
57   II,     5.  7.  6|         policies regarding RRT for ESRD. In contrast, only very
58   II,     5.  7.  6|        have been fixed for curbing ESRD in the American population.
59   II,     5.  7.  7|      kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;